N-(toluene-4-sulfonyl)-L-(5,5-dimethyl)thiaprolyl-L-4-[3-(N,N-dimethyl)propoxy]phenylalanine

ID: ALA3925460

Chembl Id: CHEMBL3925460

PubChem CID: 134141592

Max Phase: Preclinical

Molecular Formula: C27H37N3O8S2

Molecular Weight: 595.74

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1ccc(S(=O)(=O)N2CS(=O)(=O)C(C)(C)[C@@H]2C(=O)N[C@@H](Cc2ccc(OCCCN(C)C)cc2)C(=O)O)cc1

Standard InChI:  InChI=1S/C27H37N3O8S2/c1-19-7-13-22(14-8-19)40(36,37)30-18-39(34,35)27(2,3)24(30)25(31)28-23(26(32)33)17-20-9-11-21(12-10-20)38-16-6-15-29(4)5/h7-14,23-24H,6,15-18H2,1-5H3,(H,28,31)(H,32,33)/t23-,24-/m0/s1

Standard InChI Key:  BNTIBVVOAXCAIG-ZEQRLZLVSA-N

Alternative Forms

  1. Parent:

    ALA3925460

    ---

Associated Targets(Human)

ITGAL Tclin Integrin alpha-L/beta-2 (LFA-1) (51 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ITGB1 Tclin Integrin alpha-4/beta-1 (2269 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ITGB1 Tclin ITGB1-ITGA9 complex (10 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 595.74Molecular Weight (Monoisotopic): 595.2022AlogP: 1.66#Rotatable Bonds: 12
Polar Surface Area: 150.39Molecular Species: ZWITTERIONHBA: 8HBD: 2
#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: 2.74CX Basic pKa: 9.26CX LogP: -0.84CX LogD: -0.85
Aromatic Rings: 2Heavy Atoms: 40QED Weighted: 0.35Np Likeness Score: -0.82

References

1.  (2003)  Alpha-9 integrin antagonists and anti-inflammatory compositions therof, 

Source